Флударабин Актавис

Fludarabine Phosphate is a chemotherapy medication used to treat certain types of cancer, including chronic lymphocytic leukemia. It belongs to the purine antimetabolite class and is available as an injectable solution. This product is manufactured by Teva Pharma Ead and sourced from the EU.

Fludarabine Phosphate is primarily used in the treatment of hematologic malignancies such as chronic lymphocytic leukemia (CLL) and low-grade non-Hodgkin lymphoma. It works by interfering with the growth of cancer cells, helping to slow or stop their spread. This medication is often prescribed when other treatments have not been effective.

Fludarabine Phosphate may help reduce symptoms associated with certain cancers, such as fatigue, enlarged lymph nodes, or frequent infections. Patients may experience changes in blood cell counts, which can affect energy levels or immune response. Regular monitoring is typically required to assess its impact.

Fludarabine Phosphate is administered under medical supervision due to its potent effects on rapidly dividing cells. Patients should inform their healthcare provider about any infections, kidney issues, or blood disorders before starting treatment. Close monitoring of blood counts and organ function is essential during therapy.

Fludarabine Phosphate can interact with other medications that affect the immune system or blood cell production, such as immunosuppressants or certain antibiotics. Combining it with live vaccines or strong CYP inhibitors may increase the risk of side effects. Alcohol and herbal supplements should be used cautiously.